ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $973,000 | -93.2% | 21,505 | -91.6% | 0.00% | -92.6% |
Q2 2022 | $14,312,000 | -10.8% | 255,347 | +13.2% | 0.03% | +28.6% |
Q1 2022 | $16,044,000 | +44.6% | 225,625 | +32.7% | 0.02% | +61.5% |
Q4 2021 | $11,092,000 | -40.1% | 169,965 | -31.1% | 0.01% | -43.5% |
Q3 2021 | $18,504,000 | -1.0% | 246,596 | +2.9% | 0.02% | 0.0% |
Q2 2021 | $18,694,000 | -0.8% | 239,581 | +4.1% | 0.02% | -4.2% |
Q1 2021 | $18,850,000 | +17.2% | 230,166 | +18.3% | 0.02% | +14.3% |
Q4 2020 | $16,083,000 | +44.4% | 194,494 | +13.5% | 0.02% | +31.2% |
Q3 2020 | $11,137,000 | +3.8% | 171,379 | -1.0% | 0.02% | -5.9% |
Q2 2020 | $10,725,000 | +4.8% | 173,175 | +8.4% | 0.02% | -19.0% |
Q1 2020 | $10,234,000 | +369.2% | 159,823 | +328.0% | 0.02% | +425.0% |
Q1 2019 | $2,181,000 | +9382.6% | 37,338 | +9804.0% | 0.00% | – |
Q4 2018 | $23,000 | -20.7% | 377 | 0.0% | 0.00% | – |
Q3 2018 | $29,000 | -25.6% | 377 | -34.9% | 0.00% | – |
Q2 2018 | $39,000 | -4.9% | 579 | -19.4% | 0.00% | – |
Q1 2018 | $41,000 | – | 718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |